FDA Approves ‘ Biosimilar ’ Drug to Treat Certain Types of Anemia

Retacrit is biosimilar to the drugs Epogen and Procrit
Source: The Doctors Lounge - Oncology - Category: Cancer & Oncology Tags: Nephrology, Oncology, Pharmacy, AIDS, Institutional, Source Type: news